140 References Lane, A., Luminet, O., Nave, G., & Mikolajczak, M. (2016). Is there a Publication Bias in Behavioural Intranasal Oxytocin Research on Humans? Opening the File Drawer of One Laboratory. Journal of Neuroendocrinology, 28(4). https://doi.org/https://doi.org/10.1111/jne.12384 Lang, A. J., Craske, M. G., & Bjork, R. A. (1999). Implications of a new theory of disuse for the treatment of emotional disorders. Clinical Psychology: Science and Practice, 6, 80–94. https://doi. org/10.1093/clipsy.6.1.80 Lang, P. J., Bradley, M. M., & Cuthbert, B. N. (1997). Motivated attention: Affect, activation, and action. In Attention and orienting: Sensory and motivational processes. (pp. 97–135). Mahwah, NJ, US: Lawrence Erlbaum Associates Publishers. Lange, W. G., Allart, E., Keijsers, G. P. J., Rinck, M., & Becker, E. S. (2012). A neutral face is not neutral even if you have not seen it: Social anxiety disorder and affective priming with facial expressions. Cognitive Behaviour Therapy, 41(2), 108–118. https://doi.org/10.1080/16506073.2012.666563 LeDoux, J. E., Moscarello, J., Sears, R., & Campese, V. (2017). The birth, death and resurrection of avoidance: A reconceptualization of a troubled paradigm. Molecular Psychiatry, 22(1), 24–36. https://doi.org/10.1038/mp.2016.166 Leichsenring, F., Salzer, S., Beutel, M., Herpertz, S., Hiller, W., Hoyer, J., … Leibing, E. (2014). Long-Term Outcome of Psychodynamic Therapy and Cognitive-Behavioral Therapy in Social Anxiety Disorder. American Journal of Psychiatry, 171, 1074–1082. Lema, Y. Y., Gamo, N. J., Yang, K., & Ishizuka, K. (2018). Trait and state biomarkers for psychiatric disorders: Importance of infrastructure to bridge the gap between basic and clinical research and industry. Psychiatry and Clinical Neurosciences, 72(7), 482–489. https://doi.org/10.1111/pcn.12669 Leng, G., & Ludwig, M. (2016). Intranasal Oxytocin: Myths and Delusions. Biological Psychiatry, 79(3), 243–250. https://doi.org/https://doi.org/10.1016/j.biopsych.2015.05.003 Lépine, J., & Pélissolo, A. (2000). Why take social anxiety seriously? Depression and Anxiety, 92(November 1999), 87–92. Levy, T., Bloch, Y., Bar-Maisels, M., Gat-Yablonski, G., Djalovski, A., Borodkin, K., & Apter, A. (2015). Salivary oxytocin in adolescents with conduct problems and callous-unemotional traits. European Child & Adolescent Psychiatry, 24(12), 1543–1551. https://doi.org/10.1007/s00787-015-0765-6 Liebowitz, M. R. (1987). Social Phobia. Modern Problems of Pharmacopsychiatry, (22), 141–173. https:// doi.org/10.1159/000414022 Liening, S. H., Stanton, S. J., Saini, E. K., & Schultheiss, O. C. (2010). Salivary testosterone, cortisol, and progesterone: Two-week stability, interhormone correlations, and effects of time of day, menstrual cycle, and oral contraceptive use on steroid hormone levels. Physiology and Behavior, 99(1), 8–16. https://doi.org/10.1016/j.physbeh.2009.10.001 Lobbestael, J., Arntz, A., Voncken, M., & Potegal, M. (2018). Responses to dominance challenge are a function of psychopathy level: A multimethod study. Personality Disorders: Theory, Research, and Treatment, Vol. 9, pp. 305–314. https://doi.org/10.1037/per0000252 Loerinc, A. G., Meuret, A. E., Twohig, M. P., Rosen, D., Bluett, E. J., & Craske, M. G. (2015). Clinical Psychology Review Response rates for CBT for anxiety disorders : Need for standardized criteria. Clinical Psychology Review, 42, 72–82. https://doi.org/10.1016/j.cpr.2015.08.004
RkJQdWJsaXNoZXIy MTk4NDMw